Data as of May 17
| +1.58 / +3.94%|
The 15 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 40.00, with a high estimate of 48.00 and a low estimate of 27.00. The median estimate represents a -4.01% decrease from the last price of 41.67.
The current consensus among 16 polled investment analysts is to Buy stock in Mindray Medical International Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.